- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Platinum-based Anticancer APIs will have significant change from previous year. By the most conservative estimates of global Platinum-based Anticancer APIs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Platinum-based Anticancer APIs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Platinum-based Anticancer APIs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Platinum-based Anticancer APIs Consumption 2016-2026
2.1.2 Platinum-based Anticancer APIs Consumption CAGR by Region
2.2 Platinum-based Anticancer APIs Segment by Type
2.2.1 Cisplatin
2.2.2 Carboplatin
2.2.3 Oxaliplatin
2.2.4 Nedaplatin
2.2.5 Others
2.3 Platinum-based Anticancer APIs Sales by Type
2.3.1 Global Platinum-based Anticancer APIs Sales Market Share by Type (2016-2021)
2.3.2 Global Platinum-based Anticancer APIs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Platinum-based Anticancer APIs Sale Price by Type (2016-2021)
2.4 Platinum-based Anticancer APIs Segment by Application
2.4.1 Testicular Cancer
2.4.2 Osteosarcoma
2.4.3 Breast Cancer
2.4.4 Esophageal Cancer
2.4.5 NSCLC
2.4.6 Other
2.5 Platinum-based Anticancer APIs Sales by Application
2.5.1 Global Platinum-based Anticancer APIs Sale Market Share by Application (2016-2021)
2.5.2 Global Platinum-based Anticancer APIs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Platinum-based Anticancer APIs Sale Price by Application (2016-2021)
3 Global Platinum-based Anticancer APIs by Company
3.1 Global Platinum-based Anticancer APIs Sales Market Share by Company
3.1.1 Global Platinum-based Anticancer APIs Sales by Company (2019-2021)
3.1.2 Global Platinum-based Anticancer APIs Sales Market Share by Company (2019-2021)
3.2 Global Platinum-based Anticancer APIs Revenue Market Share by Company
3.2.1 Global Platinum-based Anticancer APIs Revenue by Company (2019-2021)
3.2.2 Global Platinum-based Anticancer APIs Revenue Market Share by Company (2019-2021)
3.3 Global Platinum-based Anticancer APIs Sale Price by Company
3.4 Global Manufacturers Platinum-based Anticancer APIs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Platinum-based Anticancer APIs Product Location Distribution
3.4.2 Players Platinum-based Anticancer APIs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Platinum-based Anticancer APIs by Region
4.1 Global Platinum-based Anticancer APIs by Region
4.1.1 Global Platinum-based Anticancer APIs Sales by Region
4.1.2 Global Platinum-based Anticancer APIs Revenue by Region
4.2 Americas Platinum-based Anticancer APIs Sales Growth
4.3 APAC Platinum-based Anticancer APIs Sales Growth
4.4 Europe Platinum-based Anticancer APIs Sales Growth
4.5 Middle East & Africa Platinum-based Anticancer APIs Sales Growth
5 Americas
5.1 Americas Platinum-based Anticancer APIs Sales by Country
5.1.1 Americas Platinum-based Anticancer APIs Sales by Country (2016-2021)
5.1.2 Americas Platinum-based Anticancer APIs Revenue by Country (2016-2021)
5.2 Americas Platinum-based Anticancer APIs Sales by Type
5.3 Americas Platinum-based Anticancer APIs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Platinum-based Anticancer APIs Sales by Region
6.1.1 APAC Platinum-based Anticancer APIs Sales by Region (2016-2021)
6.1.2 APAC Platinum-based Anticancer APIs Revenue by Region (2016-2021)
6.2 APAC Platinum-based Anticancer APIs Sales by Type
6.3 APAC Platinum-based Anticancer APIs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Platinum-based Anticancer APIs by Country
7.1.1 Europe Platinum-based Anticancer APIs Sales by Country (2016-2021)
7.1.2 Europe Platinum-based Anticancer APIs Revenue by Country (2016-2021)
7.2 Europe Platinum-based Anticancer APIs Sales by Type
7.3 Europe Platinum-based Anticancer APIs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Platinum-based Anticancer APIs by Country
8.1.1 Middle East & Africa Platinum-based Anticancer APIs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Platinum-based Anticancer APIs Revenue by Country (2016-2021)
8.2 Middle East & Africa Platinum-based Anticancer APIs Sales by Type
8.3 Middle East & Africa Platinum-based Anticancer APIs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Platinum-based Anticancer APIs Distributors
10.3 Platinum-based Anticancer APIs Customer
11 Global Platinum-based Anticancer APIs Market Forecast
11.1 Global Platinum-based Anticancer APIs Forecast by Region
11.1.1 Global Platinum-based Anticancer APIs Forecast by Regions (2021-2026)
11.2.2 Global Platinum-based Anticancer APIs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Platinum-based Anticancer APIs Forecast by Type
11.7 Global Platinum-based Anticancer APIs Forecast by Application
12 Key Players Analysis
12.1 Jiangsu Hengrui Medicine
12.1.1 Jiangsu Hengrui Medicine Company Information
12.1.2 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Offered
12.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Jiangsu Hengrui Medicine Main Business Overview
12.1.5 Jiangsu Hengrui Medicine Latest Developments
12.2 Nanjing Pharmaceutical Factory
12.2.1 Nanjing Pharmaceutical Factory Company Information
12.2.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Offered
12.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Nanjing Pharmaceutical Factory Main Business Overview
12.2.5 Nanjing Pharmaceutical Factory Latest Developments
12.3 Qilu Pharmaceutical
12.3.1 Qilu Pharmaceutical Company Information
12.3.2 Qilu Pharmaceutical Platinum-based Anticancer APIs Product Offered
12.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Qilu Pharmaceutical Main Business Overview
12.3.5 Qilu Pharmaceutical Latest Developments
12.4 Neptunus
12.4.1 Neptunus Company Information
12.4.2 Neptunus Platinum-based Anticancer APIs Product Offered
12.4.3 Neptunus Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Neptunus Main Business Overview
12.4.5 Neptunus Latest Developments
12.5 Hisun
12.5.1 Hisun Company Information
12.5.2 Hisun Platinum-based Anticancer APIs Product Offered
12.5.3 Hisun Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Hisun Main Business Overview
12.5.5 Hisun Latest Developments
12.6 Jiangsu HaiCi biological pharmaceutical
12.6.1 Jiangsu HaiCi biological pharmaceutical Company Information
12.6.2 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Offered
12.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Jiangsu HaiCi biological pharmaceutical Main Business Overview
12.6.5 Jiangsu HaiCi biological pharmaceutical Latest Developments
12.7 Kunming Guiyan Pharmaceutical
12.7.1 Kunming Guiyan Pharmaceutical Company Information
12.7.2 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Offered
12.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Kunming Guiyan Pharmaceutical Main Business Overview
12.7.5 Kunming Guiyan Pharmaceutical Latest Developments
12.8 Lingnan Pharmacy
12.8.1 Lingnan Pharmacy Company Information
12.8.2 Lingnan Pharmacy Platinum-based Anticancer APIs Product Offered
12.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Lingnan Pharmacy Main Business Overview
12.8.5 Lingnan Pharmacy Latest Developments
12.9 Jinzhou Jiutai Pharmaceutical
12.9.1 Jinzhou Jiutai Pharmaceutical Company Information
12.9.2 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Offered
12.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Jinzhou Jiutai Pharmaceutical Main Business Overview
12.9.5 Jinzhou Jiutai Pharmaceutical Latest Developments
12.10 Nanjing Hairun Pharmaceutical
12.10.1 Nanjing Hairun Pharmaceutical Company Information
12.10.2 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Offered
12.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Nanjing Hairun Pharmaceutical Main Business Overview
12.10.5 Nanjing Hairun Pharmaceutical Latest Developments
12.11 Simcere
12.11.1 Simcere Company Information
12.11.2 Simcere Platinum-based Anticancer APIs Product Offered
12.11.3 Simcere Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Simcere Main Business Overview
12.11.5 Simcere Latest Developments
12.12 Teva
12.12.1 Teva Company Information
12.12.2 Teva Platinum-based Anticancer APIs Product Offered
12.12.3 Teva Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Teva Main Business Overview
12.12.5 Teva Latest Developments
12.13 Cipla
12.13.1 Cipla Company Information
12.13.2 Cipla Platinum-based Anticancer APIs Product Offered
12.13.3 Cipla Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Cipla Main Business Overview
12.13.5 Cipla Latest Developments
12.14 Heraeus
12.14.1 Heraeus Company Information
12.14.2 Heraeus Platinum-based Anticancer APIs Product Offered
12.14.3 Heraeus Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Heraeus Main Business Overview
12.14.5 Heraeus Latest Developments
12.15 Hospira(Pfizer)
12.15.1 Hospira(Pfizer) Company Information
12.15.2 Hospira(Pfizer) Platinum-based Anticancer APIs Product Offered
12.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Hospira(Pfizer) Main Business Overview
12.15.5 Hospira(Pfizer) Latest Developments
12.16 Taj Pharmaceuticals
12.16.1 Taj Pharmaceuticals Company Information
12.16.2 Taj Pharmaceuticals Platinum-based Anticancer APIs Product Offered
12.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Taj Pharmaceuticals Main Business Overview
12.16.5 Taj Pharmaceuticals Latest Developments
12.17 Umicore Precious Metals Chemistry
12.17.1 Umicore Precious Metals Chemistry Company Information
12.17.2 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Offered
12.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Umicore Precious Metals Chemistry Main Business Overview
12.17.5 Umicore Precious Metals Chemistry Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Platinum-based Anticancer APIs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Cisplatin
Table 3. Major Players of Carboplatin
Table 4. Major Players of Oxaliplatin
Table 5. Major Players of Nedaplatin
Table 6. Major Players of Others
Table 7. Global Platinum-based Anticancer APIs Sales by Type (2016-2021) & (Kiloton)
Table 8. Global Platinum-based Anticancer APIs Sales Market Share by Type (2016-2021)
Table 9. Global Platinum-based Anticancer APIs Revenue by Type (2016-2021) & ($ million)
Table 10. Global Platinum-based Anticancer APIs Revenue Market Share by Type (2016-2021)
Table 11. Global Platinum-based Anticancer APIs Sale Price by Type (2016-2021)
Table 12. Global Platinum-based Anticancer APIs Sales by Application (2016-2021) & (Kiloton)
Table 13. Global Platinum-based Anticancer APIs Sales Market Share by Application (2016-2021)
Table 14. Global Platinum-based Anticancer APIs Value by Application (2016-2021)
Table 15. Global Platinum-based Anticancer APIs Revenue Market Share by Application (2016-2021)
Table 16. Global Platinum-based Anticancer APIs Sale Price by Application (2016-2021)
Table 17. Global Platinum-based Anticancer APIs Sales by Company (2019-2021) & (Kiloton)
Table 18. Global Platinum-based Anticancer APIs Sales Market Share by Company (2019-2021)
Table 19. Global Platinum-based Anticancer APIs Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Platinum-based Anticancer APIs Revenue Market Share by Company (2019-2021)
Table 21. Global Platinum-based Anticancer APIs Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Platinum-based Anticancer APIs Producing Area Distribution and Sales Area
Table 23. Players Platinum-based Anticancer APIs Products Offered
Table 24. Platinum-based Anticancer APIs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Platinum-based Anticancer APIs Sales by Region (2016-2021) (Kiloton)
Table 28. Global Platinum-based Anticancer APIs Sales Market Share by Region (2016-2021)
Table 29. Global Platinum-based Anticancer APIs Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Platinum-based Anticancer APIs Revenue Market Share by Region (2016-2021)
Table 31. Americas Platinum-based Anticancer APIs Sales by Country (2016-2021) & (Kiloton)
Table 32. Americas Platinum-based Anticancer APIs Sales Market Share by Country (2016-2021)
Table 33. Americas Platinum-based Anticancer APIs Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Platinum-based Anticancer APIs Revenue Market Share by Country (2016-2021)
Table 35. Americas Platinum-based Anticancer APIs Sales by Type (2016-2021) & (Kiloton)
Table 36. Americas Platinum-based Anticancer APIs Sales Market Share by Type (2016-2021)
Table 37. Americas Platinum-based Anticancer APIs Sales by Application (2016-2021) & (Kiloton)
Table 38. Americas Platinum-based Anticancer APIs Sales Market Share by Application (2016-2021)
Table 39. APAC Platinum-based Anticancer APIs Sales by Region (2016-2021) & (Kiloton)
Table 40. APAC Platinum-based Anticancer APIs Sales Market Share by Region (2016-2021)
Table 41. APAC Platinum-based Anticancer APIs Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Platinum-based Anticancer APIs Revenue Market Share by Region (2016-2021)
Table 43. APAC Platinum-based Anticancer APIs Sales by Type (2016-2021) & (Kiloton)
Table 44. APAC Platinum-based Anticancer APIs Sales Market Share by Type (2016-2021)
Table 45. APAC Platinum-based Anticancer APIs Sales by Application (2016-2021) & (Kiloton)
Table 46. APAC Platinum-based Anticancer APIs Sales Market Share by Application (2016-2021)
Table 47. Europe Platinum-based Anticancer APIs Sales by Country (2016-2021) & (Kiloton)
Table 48. Europe Platinum-based Anticancer APIs Sales Market Share by Country (2016-2021)
Table 49. Europe Platinum-based Anticancer APIs Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Platinum-based Anticancer APIs Revenue Market Share by Country (2016-2021)
Table 51. Europe Platinum-based Anticancer APIs Sales by Type (2016-2021) & (Kiloton)
Table 52. Europe Platinum-based Anticancer APIs Sales Market Share by Type (2016-2021)
Table 53. Europe Platinum-based Anticancer APIs Sales by Application (2016-2021) & (Kiloton)
Table 54. Europe Platinum-based Anticancer APIs Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Platinum-based Anticancer APIs Sales by Country (2016-2021) & (Kiloton)
Table 56. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Platinum-based Anticancer APIs Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Platinum-based Anticancer APIs Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Platinum-based Anticancer APIs Sales by Type (2016-2021) & (Kiloton)
Table 60. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Platinum-based Anticancer APIs Sales by Application (2016-2021) & (Kiloton)
Table 62. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Platinum-based Anticancer APIs
Table 64. Key Application and Potential Industries of Platinum-based Anticancer APIs
Table 65. Key Challenges of Platinum-based Anticancer APIs
Table 66. Key Trends of Platinum-based Anticancer APIs
Table 67. Platinum-based Anticancer APIs Distributors List
Table 68. Platinum-based Anticancer APIs Customer List
Table 69. Global Platinum-based Anticancer APIs Sales Forecast by Region (2021-2026) & (Kiloton)
Table 70. Global Platinum-based Anticancer APIs Consumption Market Forecast by Region
Table 71. Global Platinum-based Anticancer APIs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Platinum-based Anticancer APIs Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Platinum-based Anticancer APIs Sales Forecast by Country (2021-2026) & (Kiloton)
Table 74. Americas Platinum-based Anticancer APIs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Platinum-based Anticancer APIs Sales Forecast by Region (2021-2026) & (Kiloton)
Table 76. APAC Platinum-based Anticancer APIs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Platinum-based Anticancer APIs Sales Forecast by Country (2021-2026) & (Kiloton)
Table 78. Europe Platinum-based Anticancer APIs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Platinum-based Anticancer APIs Sales Forecast by Country (2021-2026) & (Kiloton)
Table 80. Middle East & Africa Platinum-based Anticancer APIs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Platinum-based Anticancer APIs Sales Forecast by Type (2021-2026) & (Kiloton)
Table 82. Global Platinum-based Anticancer APIs Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Platinum-based Anticancer APIs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Platinum-based Anticancer APIs Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Platinum-based Anticancer APIs Sales Forecast by Application (2021-2026) & (Kiloton)
Table 86. Global Platinum-based Anticancer APIs Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Platinum-based Anticancer APIs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Platinum-based Anticancer APIs Revenue Market Share Forecast by Application (2021-2026)
Table 89. Jiangsu Hengrui Medicine Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 90. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Offered
Table 91. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 92. Jiangsu Hengrui Medicine Main Business
Table 93. Jiangsu Hengrui Medicine Latest Developments
Table 94. Nanjing Pharmaceutical Factory Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 95. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Offered
Table 96. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 97. Nanjing Pharmaceutical Factory Main Business
Table 98. Nanjing Pharmaceutical Factory Latest Developments
Table 99. Qilu Pharmaceutical Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 100. Qilu Pharmaceutical Platinum-based Anticancer APIs Product Offered
Table 101. Qilu Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 102. Qilu Pharmaceutical Main Business
Table 103. Qilu Pharmaceutical Latest Developments
Table 104. Neptunus Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 105. Neptunus Platinum-based Anticancer APIs Product Offered
Table 106. Neptunus Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 107. Neptunus Main Business
Table 108. Neptunus Latest Developments
Table 109. Hisun Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 110. Hisun Platinum-based Anticancer APIs Product Offered
Table 111. Hisun Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 112. Hisun Main Business
Table 113. Hisun Latest Developments
Table 114. Jiangsu HaiCi biological pharmaceutical Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 115. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Offered
Table 116. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 117. Jiangsu HaiCi biological pharmaceutical Main Business
Table 118. Jiangsu HaiCi biological pharmaceutical Latest Developments
Table 119. Kunming Guiyan Pharmaceutical Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 120. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Offered
Table 121. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 122. Kunming Guiyan Pharmaceutical Main Business
Table 123. Kunming Guiyan Pharmaceutical Latest Developments
Table 124. Lingnan Pharmacy Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 125. Lingnan Pharmacy Platinum-based Anticancer APIs Product Offered
Table 126. Lingnan Pharmacy Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 127. Lingnan Pharmacy Main Business
Table 128. Lingnan Pharmacy Latest Developments
Table 129. Jinzhou Jiutai Pharmaceutical Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 130. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Offered
Table 131. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 132. Jinzhou Jiutai Pharmaceutical Main Business
Table 133. Jinzhou Jiutai Pharmaceutical Latest Developments
Table 134. Nanjing Hairun Pharmaceutical Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 135. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Offered
Table 136. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 137. Nanjing Hairun Pharmaceutical Main Business
Table 138. Nanjing Hairun Pharmaceutical Latest Developments
Table 139. Simcere Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 140. Simcere Platinum-based Anticancer APIs Product Offered
Table 141. Simcere Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 142. Simcere Main Business
Table 143. Simcere Latest Developments
Table 144. Teva Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 145. Teva Platinum-based Anticancer APIs Product Offered
Table 146. Teva Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 147. Teva Main Business
Table 148. Teva Latest Developments
Table 149. Cipla Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 150. Cipla Platinum-based Anticancer APIs Product Offered
Table 151. Cipla Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 152. Cipla Main Business
Table 153. Cipla Latest Developments
Table 154. Heraeus Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 155. Heraeus Platinum-based Anticancer APIs Product Offered
Table 156. Heraeus Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 157. Heraeus Main Business
Table 158. Heraeus Latest Developments
Table 159. Hospira(Pfizer) Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 160. Hospira(Pfizer) Platinum-based Anticancer APIs Product Offered
Table 161. Hospira(Pfizer) Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 162. Hospira(Pfizer) Main Business
Table 163. Hospira(Pfizer) Latest Developments
Table 164. Taj Pharmaceuticals Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 165. Taj Pharmaceuticals Platinum-based Anticancer APIs Product Offered
Table 166. Taj Pharmaceuticals Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 167. Taj Pharmaceuticals Main Business
Table 168. Taj Pharmaceuticals Latest Developments
Table 169. Umicore Precious Metals Chemistry Basic Information, Platinum-based Anticancer APIs Manufacturing Base, Sales Area and Its Competitors
Table 170. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Offered
Table 171. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 172. Umicore Precious Metals Chemistry Main Business
Table 173. Umicore Precious Metals Chemistry Latest Developments
List of Figures
Figure 1. Picture of Platinum-based Anticancer APIs
Figure 2. Platinum-based Anticancer APIs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Platinum-based Anticancer APIs Sales Growth Rate 2016-2026 (Kiloton)
Figure 7. Global Platinum-based Anticancer APIs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Platinum-based Anticancer APIs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Cisplatin
Figure 10. Product Picture of Carboplatin
Figure 11. Product Picture of Oxaliplatin
Figure 12. Product Picture of Nedaplatin
Figure 13. Product Picture of Others
Figure 14. Global Platinum-based Anticancer APIs Sales Market Share by Type in 2020
Figure 15. Global Platinum-based Anticancer APIs Revenue Market Share by Type (2016-2021)
Figure 16. Platinum-based Anticancer APIs Consumed in Testicular Cancer
Figure 17. Global Platinum-based Anticancer APIs Market: Testicular Cancer (2016-2021) & (Kiloton)
Figure 18. Platinum-based Anticancer APIs Consumed in Osteosarcoma
Figure 19. Global Platinum-based Anticancer APIs Market: Osteosarcoma (2016-2021) & (Kiloton)
Figure 20. Platinum-based Anticancer APIs Consumed in Breast Cancer
Figure 21. Global Platinum-based Anticancer APIs Market: Breast Cancer (2016-2021) & (Kiloton)
Figure 22. Platinum-based Anticancer APIs Consumed in Esophageal Cancer
Figure 23. Global Platinum-based Anticancer APIs Market: Esophageal Cancer (2016-2021) & (Kiloton)
Figure 24. Platinum-based Anticancer APIs Consumed in NSCLC
Figure 25. Global Platinum-based Anticancer APIs Market: NSCLC (2016-2021) & (Kiloton)
Figure 26. Platinum-based Anticancer APIs Consumed in Other
Figure 27. Global Platinum-based Anticancer APIs Market: Other (2016-2021) & (Kiloton)
Figure 28. Global Platinum-based Anticancer APIs Sales Market Share by Application (2016-2021)
Figure 29. Global Platinum-based Anticancer APIs Revenue Market Share by Application in 2020
Figure 30. Platinum-based Anticancer APIs Revenue Market by Company in 2020 ($ Million)
Figure 31. Global Platinum-based Anticancer APIs Revenue Market Share by Company in 2020
Figure 32. Global Platinum-based Anticancer APIs Sales Market Share by Regions (2016-2021)
Figure 33. Global Platinum-based Anticancer APIs Revenue Market Share by Region in 2020
Figure 34. Americas Platinum-based Anticancer APIs Sales 2016-2021 (Kiloton)
Figure 35. Americas Platinum-based Anticancer APIs Revenue 2016-2021 ($ Millions)
Figure 36. APAC Platinum-based Anticancer APIs Sales 2016-2021 (Kiloton)
Figure 37. APAC Platinum-based Anticancer APIs Revenue 2016-2021 ($ Millions)
Figure 38. Europe Platinum-based Anticancer APIs Sales 2016-2021 (Kiloton)
Figure 39. Europe Platinum-based Anticancer APIs Revenue 2016-2021 ($ Millions)
Figure 40. Middle East & Africa Platinum-based Anticancer APIs Sales 2016-2021 (Kiloton)
Figure 41. Middle East & Africa Platinum-based Anticancer APIs Revenue 2016-2021 ($ Millions)
Figure 42. Americas Platinum-based Anticancer APIs Sales Market Share by Country in 2020
Figure 43. Americas Platinum-based Anticancer APIs Revenue Market Share by Country in 2020
Figure 44. Americas Platinum-based Anticancer APIs Sales Market Share by Type in 2020
Figure 45. Americas Platinum-based Anticancer APIs Sales Market Share by Application in 2020
Figure 46. United States Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Canada Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Mexico Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Brazil Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 50. APAC Platinum-based Anticancer APIs Sales Market Share by Region in 2020
Figure 51. APAC Platinum-based Anticancer APIs Revenue Market Share by Regions in 2020
Figure 52. APAC Platinum-based Anticancer APIs Sales Market Share by Type in 2020
Figure 53. APAC Platinum-based Anticancer APIs Sales Market Share by Application in 2020
Figure 54. China Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Japan Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Korea Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Southeast Asia Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 58. India Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Australia Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Europe Platinum-based Anticancer APIs Sales Market Share by Country in 2020
Figure 61. Europe Platinum-based Anticancer APIs Revenue Market Share by Country in 2020
Figure 62. Europe Platinum-based Anticancer APIs Sales Market Share by Type in 2020
Figure 63. Europe Platinum-based Anticancer APIs Sales Market Share by Application in 2020
Figure 64. Germany Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 65. France Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 66. UK Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Italy Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Russia Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Country in 2020
Figure 70. Middle East & Africa Platinum-based Anticancer APIs Revenue Market Share by Country in 2020
Figure 71. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Type in 2020
Figure 72. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Application in 2020
Figure 73. Egypt Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 74. South Africa Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Israel Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 76. Turkey Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 77. GCC Country Platinum-based Anticancer APIs Revenue Growth 2016-2021 ($ Millions)
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
